Dynamic Cellular Origins of Circulating DAMPs and Their Role in Thromboinflammation During Sepsis
Year: 2026
Type: article
Abstract: Circulating damage-associated molecular patterns (DAMPs) are associated with injury and adverse outcomes in sepsis, but their concentrations do not identify their cellular origins or rates of release. This narrative review compares nuclear cell-free DNA, mitochondrial DNA, HMGB1, extracellular histones, nucleosomes, ATP, heat shock proteins, extracellular RNA, and NAD+, with attention to source specificity, extracellular persistence, and assay limitations. Human methylation studies identify leukocyte and parenchymal contributions to nuclear cell-free DNA, while experimental models demonstrate that nonhematopoietic contributions can emerge alongside ongoing hematopoietic release. These findings motivate a temporal framework in which leukocyte activation, endothelial injury, and parenchymal injury overlap. Their order and relative contributions remain hypotheses that may differ among patients and mediators. Degradation, clearance, and redistribution also shape the measured circulating pool. We distinguish experimental mechanisms from clinical associations and propose serial sampling anchored to sepsis recognition, accompanied by organ function and coagulation assessments. Source-resolved measurements may support prognostic assessment and trial stratification, but their incremental value and ability to predict treatment response require prospective validation. A DAMP concentration should therefore be interpreted together with sampling time, molecular form, and clinical context.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm15229046
Language: English
Field: Medicine
Domain: Health Sciences
Keywords: damage-associated molecular patterns, sepsis, thromboinflammation, cell-free DNA, mitochondrial DNA, HMGB1, extracellular histones, nucleosome, ATP, heat shock proteins, extracellular RNA, NAD+, leukocyte activation, endothelial injury, parenchymal injury, serial sampling, prognostic factors, trial stratification
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236501408
